Tag Archives: GlaxoSmithKline PLC

GlaxoSmithKline Taps Apple’s ResearchKit for Arthritis Study

GlaxoSmithKline PLC (London) has started a rheumatoid arthritis study using Apple Inc.’s (Cupertino CA) ResearchKit, marking the first time a drugmaker has used the health system for the iPhone to… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

Brexit Bargain Stocks Require Creative Mindset, Risk Tolerance

Frenzied bargain-hunters will immediately delve into the carnage of markets in the post-Brexit earthquake. Analysts advise caution but, more importantly, think creatively. The most obvious places to look are among… Read more »

Glaxo Accelerates Regulatory Plan for Triple Combo Treatment for COPD

GlaxoSmithKline PLC (London) moved to consolidate its lead in a new class of three-in-one inhaled lung drugs on Thursday with plans to file its product for U.S. approval by the… Read more »

U.S. Lawmakers Approve Bill to Provide Financial Incentives to Companies Developing Treatments for the Zika Virus

U.S. lawmakers last week approved a bill to provide financial incentives to companies developing treatments for the Zika virus, sending the measure on to the White House for President Barack… Read more »